CARLOMAGNO, Chiara
CARLOMAGNO, Chiara
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Cancro del colon-retto
1999 Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar
Correlation between bevacizumab-related hypertension and response in mCRC patients
2010 DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino
Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models
2012 Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino
Naoadjuvant chemoradiation therapy with capecitabine (CAP) and oxaliplatin (OX) in rectal cancer: final results of a phase II study
2008 Carlomagno, Chiara; D'Armiento, FRANCESCO PAOLO; Farella, A; Cannella, L; De Stefano, A; Colantuoni, M; Alfieri, S; Marra, M; Totaro, G; Pepe, S.
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part
2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Double complete response in MCRC patient
2009 DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino
High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts)
2012 De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses.
2015 Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone
MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS
2009 M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino
Cancro del colon-retto
2011 Carlomagno, Chiara; DE PLACIDO, Sabino
HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies
2002 DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco
MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer
2011 G., Della Vittoria Scarpati; DE STEFANO, Alfonso; F., Falcetta; Carlomagno, Chiara; P., Ubezio; S., Marchini; M., D'Incalci; DE PLACIDO, Sabino; S., Pepe
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study.
2006 Orditura, M; Martinelli, E; Galizia, G; Carlomagno, Chiara; Aurilio, G; Vecchione, L; Lieto, E; DE PLACIDO, Sabino; Catalano, G; Ciardiello, F; DE VITA, F.
Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom?
2014 DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara
A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
2014 D'Alterio, C; Avallone, A; Tatangelo, F; Delrio, P; Pecori, B; Cella, L; Pelella, A; D'Armiento, FRANCESCO PAOLO; Carlomagno, Chiara; Bianco, F; Silvestro, L; Pacelli, Roberto; Napolitano, M; Iaffaioli, Rv; Scala, Stefania
Bevacizumab maintenance in metastatic colorectal cancer: How long?
2014 DE STEFANO, Alfonso; Moretto, R; Cella, Ca; Romano, Fj; Raimondo, L; Fiore, G; Di Pietro, F; Pepe, S; DE PLACIDO, Sabino; Carlomagno, Chiara
FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience
2013 Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara
Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer.
1995 Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses.
2003 Baum, M; Buzdar, A; Cuzick, J; Forbes, J; Houghton, J; Howell, A; Sahmoud, T; ATAC Trialists', Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 1999 | Carlomagno, Chiara; DE PLACIDO, Sabino; Bianco, Ar | |
| Correlation between bevacizumab-related hypertension and response in mCRC patients | 1.5 Abstract in rivista | 2010 | DE STEFANO, Alfonso; L., Cannella; Carlomagno, Chiara; A., Crispo; Bianco, Roberto; Marciano, Roberta; Pepe, Stefano; DE PLACIDO, Sabino | |
| Role of sphingosine kinase 1 (SphK1) on cetuximab resistance in colorectal cancer models | 1.5 Abstract in rivista | 2012 | Bianco, Roberto; R., Rosa; L., Nappi; Formisano, Luigi; V., Damiano; C., D'Amato; A. P., de Maio; Marciano, Roberta; Malapelle, Umberto; Troncone, Giancarlo; Carlomagno, Chiara; DE STEFANO, Alfonso; G., Tortora; DE PLACIDO, Sabino | |
| Naoadjuvant chemoradiation therapy with capecitabine (CAP) and oxaliplatin (OX) in rectal cancer: final results of a phase II study | 1.5 Abstract in rivista | 2008 | Carlomagno, Chiara; D'Armiento, FRANCESCO PAOLO; Farella, A; Cannella, L; De Stefano, A; Colantuoni, M; Alfieri, S; Marra, M; Totaro, G; Pepe, S. | |
| Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part | 1.5 Abstract in rivista | 2007 | G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino | |
| Double complete response in MCRC patient | 1.5 Abstract in rivista | 2009 | DE STEFANO, Alfonso; Carlomagno, Chiara; L., Cannella; S., Alfieri; M., Colantuoni; Ca, Cella; DE PLACIDO, Sabino | |
| High-rsolution melting analysis (HRMA) for KRAS mutatiinal study in patients with metastatic colorectal cancer (mCRC pts) | 1.5 Abstract in rivista | 2012 | De Stefano, A; Malapelle, Umberto; Carlomagno, Chiara; Bianco, Roberto; Marciano, Roberta; Cimminiello, C; Colantuoni, M; DE PLACIDO, Sabino; Troncone, Giancarlo | |
| FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as initial treatment for metastatic colorectal cancer (TRIBE study): updated survival results and final molecular subgroups analyses. | 1.5 Abstract in rivista | 2015 | Fotios, Loupakis; Chiara, Cremolini; Carlotta, Antoniotti; Sara, Lonardi; Monica, Ronzoni; Alberto, Zaniboni; Giuseppe, Tonini; Lisa, Salvatore; Silvana, Chiara; Carlomagno, Chiara; Chiara, Banzi; Francesca, Negri; Lorenzo, Marcucci; Carlo, Barone; Gabriella, Fontanini; Nicla, Borrelli; Mirella, Giordano; Elisabetta, Macerola; Luca, Boni; Alfredo, Falcone | |
| MULTIPLE PRIMARY MALIGNANT NEOPLASM AND FAMILIAR ANAMNESIS | 1.5 Abstract in rivista | 2009 | M., Colantuoni; Carlomagno, Chiara; L., Cannella; S., Alfieri; DE STEFANO, Alfonso; Ca, Cella; DE PLACIDO, Sabino | |
| Cancro del colon-retto | 2.1 Contributo in volume (Capitolo o Saggio) | 2011 | Carlomagno, Chiara; DE PLACIDO, Sabino | |
| HER2 as predictive marker of resistance to endocrine treatment for advanced bresat cancer: a metanalysis of published studies | 1.5 Abstract in rivista | 2002 | DE LAURENTIIS, Michelino; Arpino, Grazia; E., Massarelli; A., Ruggiero; Carlomagno, Chiara; G., Tortora; F., Ciardiello; Ar, Bianco | |
| MicroRNA profiling as predictive factor of complete pathological response to neoadjuvant chemoradiothetapy in patients with locally advanced cancer | 1.5 Abstract in rivista | 2011 | G., Della Vittoria Scarpati; DE STEFANO, Alfonso; F., Falcetta; Carlomagno, Chiara; P., Ubezio; S., Marchini; M., D'Incalci; DE PLACIDO, Sabino; S., Pepe | |
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| Weekly docetaxel and capecitabine is not effective in the treatment of advanced gastric cancer: a phase II study. | 1.1 Articolo in rivista | 2006 | Orditura, M; Martinelli, E; Galizia, G; Carlomagno, Chiara; Aurilio, G; Vecchione, L; Lieto, E; DE PLACIDO, Sabino; Catalano, G; Ciardiello, F; DE VITA, F. | |
| Adjuvant treatment for locally advanced rectal cancer patients after pre-operative chemoradiotherapy: when, and for whom? | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Moretto, R; Bucci, Luigi; Pepe, S; Romano, Fj; Cella, Ca; Attademo, L; Rosanova, M; De Falco, S; Fiore, G; Raimondo, L; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients. | 1.1 Articolo in rivista | 2014 | D'Alterio, C; Avallone, A; Tatangelo, F; Delrio, P; Pecori, B; Cella, L; Pelella, A; D'Armiento, FRANCESCO PAOLO; Carlomagno, Chiara; Bianco, F; Silvestro, L; Pacelli, Roberto; Napolitano, M; Iaffaioli, Rv; Scala, Stefania | |
| Bevacizumab maintenance in metastatic colorectal cancer: How long? | 1.1 Articolo in rivista | 2014 | DE STEFANO, Alfonso; Moretto, R; Cella, Ca; Romano, Fj; Raimondo, L; Fiore, G; Di Pietro, F; Pepe, S; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| FOLFIRI in patients with locally advanced or metastatic pancreatic or biliary tract carcinoma: a monoinstitutional experience | 1.1 Articolo in rivista | 2013 | Moretto, Roberto; Raimondo, Lucia; DE STEFANO, Alfonso; Cella, CHIARA ALESSANDRA; Matano, E; DE PLACIDO, Sabino; Carlomagno, Chiara | |
| Prognostic significance of necrosis, elestosis, fibrosis and inflammatory cell reaction in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Carlomagno, Chiara; Perrone, F.; Lauria, R.; DE LAURENTIIS, Michelino; Gallo, C.; Morabito, A.; Pettinato, Guido; Panico, L.; Bellelli, T.; Apicella, A.; Putrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update analyses. | 1.1 Articolo in rivista | 2003 | Baum, M; Buzdar, A; Cuzick, J; Forbes, J; Houghton, J; Howell, A; Sahmoud, T; ATAC Trialists', Group; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Carlomagno, Chiara |